Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Kangrui Pharmaceutical is a China-based pharmaceutical company primarily engaged in the research, development, and manufacturing of chemical drug substances and finished dosage forms. The company operates a production base in Tianjin that adheres to Good Manufacturing Practice (GMP) standards, focusing on a variety of therapeutic areas including gastrointestinal health and cardiovascular medicine. Its product portfolio includes both active pharmaceutical ingredients (APIs) and oral solid preparations. Tianjin Kangrui Pharmaceutical serves the domestic Chinese market while also seeking opportunities for international export of its chemical intermediates and finished products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Kangrui Pharmaceutical.